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SNPing at the Epidermal Barrier
David P. Kelsell1 and Carolyn Byrne1
Filaggrin variants are well-established risk factors for atopic eczema (AE). 
Recent studies suggest additional epidermal differentiation complex (EDC) 
gene associations with AE. In this issue, Marenholz and colleagues confirm this 
prediction and show that a small proline-rich protein 3 (SPRR3) variant confers 
susceptibility to AE. This finding suggests that further genetic and functional 
characterization of SPRR3 should be performed in patients with AE.
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The chromosomal region 1q21.3 (the 
epidermal differentiation complex, 
or EDC) has been widely studied 
in epidermal biology and disease 
because it harbors a large number of 
genes (around 60) expressed in late 
keratinocyte differentiation (Mischke 
et al., 1996). These include genes 
encoding proteins such as filag-
grin (FLG), loricin, and gene family 
clusters, including the late cornified 
envelope genes, S100s, and the small 
proline-rich proteins (SPRRs). They are 
involved in various aspects of stratum 
corneum formation, including keratin 
filament aggregation (FLG) and corni-
fied envelope formation (loricin), or 
are implicated in host defense (the 
S100s). Mutations in FLG and loricin 
are associated with ichthyosis vulgaris 
(Smith et al., 2006) and a variant of 
Vohwinkel’s syndrome (Maestrini et 
al., 1996), respectively. However, the 
most striking finding has been that 
loss-of-function mutations in FLG are 
strongly associated with atopic ecze-
ma (AE), implicating an impaired epi-
dermal barrier in the development of 
this chronic inflammatory skin disease 
that affects up to 20% of children in 
some countries (Palmer et al., 2006).
It is thus intriguing that FLG 
appears to be the main culprit in the 
EDC for AE susceptibility, although 
other EDC genes could be predicted 
to have similar deleterious effects 
on epidermal barrier function. Three 
recent areas of genetic investigation 
suggest that FLG may not be solely 
responsible. First, genetic studies 
(Cascella et al., 2011; Sinclair et al., 
2009) show that, although present, 
FLG mutations are not strongly impli-
cated in AE susceptibility in Italian 
and Bangladeshi populations. Second, 
expression studies show dysregulation 
of a number of EDC proteins in AE skin 
(Sugiura et al., 2005; Saaf et al., 2008; 
Guttman-Yassky et al., 2009). Third, a 
genome-wide association study sup-
ports another locus (or loci) associated 
with AE within the EDC (Esparza-
Gordillo et al., 2009). The latter, in 
particular, led Marenholz et al. (2011, 
this issue) to investigate whether 
coding sequence variants in other EDC 
genes were associated with AE.
The investigators examined the 
National Center for Biotechnology 
Information (NCBI) database to 
identify likely deleterious coding 
sequence variants in other EDC genes, 
primarily insertion/deletion, frame-
shift, and stop codon mutations. They 
selected 20 such variants and found 
that rs28989168 (variant allele is an 
in-frame 24-bp insertion in SPRR3) 
was associated with eczema after 
replication studies (odds ratio of 1.30). 
These data demonstrate two distinct 
proteins within the EDC that are linked 
to the impaired epidermal barrier func-
tion associated with AE susceptibility.
SPRR family members are thought to 
have a structural role in the cornified 
envelope as linkers for transglutami-
nase-mediated protein cross-bridging 
(Steinert et al., 1998), and they have 
been proposed as reactive oxygen 
species quenchers, with an impor-
tant function at the edges of wounds 
(Vermeij and Backendorf, 2010). 
SPRR proteins contain glutamine and 
lysine-rich N- and C-termini, which 
provide transglutaminase substrates. 
The termini flank 8- to 9-amino-acid 
proline-rich internal repeats, varying 
in sequence and number among fam-
ily members, and act as flexible, cross-
bridging spacers (Steinert et al., 1998). 
Repeat variability is thought to confer 
differences in flexibility, strength, and 
toughness to the stratum corneum. 
Accordingly, Marenholz et al. (2011) 
speculate that the eczema-associated 
SPRR3 variant, with an additional 
8-amino-acid repeat, influences bar-
rier function by altering the physical 
properties of the stratum corneum.
SPRR3 is a surprise candidate for 
a functionally important skin barrier 
gene in that it is abundantly expressed 
in internal epithelia (for example, the 
tongue, esophagus, and tonsil) and 
undetectable in normal skin (Cabral 
et al., 2001; BioGPS, http://biogps.gnf.
org). Its identification as a skin bar-
rier component suggests that minor 
stratum corneum protein components 
can substantially affect barrier 
function. Alternatively, the SPRR3 
variant may influence skin barrier 
activity as part of a skin stress response 
because the expression of SPRR pro-
teins increases in response to diverse 
influences including UVR, aging, 
cancer, and wound healing (Vermeij 
and Backendorf, 2010; Cabral et al., 
2001, and references therein). A role 
for SPRR3 in events triggering eczema 
outbreaks (for example, repair of bar-
rier microlesions after scratching or 
in response to infection) is plausible, 
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and its function in skin requires further 
elucidation.
Another surprising finding reported 
by Marenholz et al. (2011) is the large 
number of sequence variants anno-
tated in the NCBI database that they 
could not find in their patient samples, 
with only 4 of 20 being experimentally 
validated. The investigators suggested 
this may be attributable to the rarity of 
these alleles (although they tested 94 
individuals), their population specific-
ity, or their being sequence artifacts. 
We have revisited these original 20 
sequence variants in a newer build 
of the human genome sequence; we 
also looked for their presence in the 
1,000-genome database accessed via 
Ensembl, and we suggest that the 16 
unvalidated variants were likely to be 
artifacts. For example, of the four FLG2 
single-nucleotide polymorphisms 
(SNPs) genotyped by Marenholz et al., 
only rs12568784 (the only FLG2 SNP 
they experimentally validated by PCR) 
was found in the 1,000-genome data-
set. In light of this, we revisited SPRR3 
to determine what other potentially 
deleterious sequence variants or SNPs 
have been annotated in the current 
sequence build. Table 1 shows that 
further SPRR3 coding variants war-
rant investigation as risk factors linked 
to AE susceptibility. These include 
two 8-amino-acid insertion/deletion 
sequence variants (rs67156933 
and rs66616552) in addition to the 
AE-associated rs28989168, suggesting 
that these should also be assessed for 
association with AE.
The study by Marenholz et al. 
(2011) highlights how complex the 
genetic makeup of AE susceptibility 
is likely to be. On the other hand, it 
emphasizes that the epidermal bar-
rier is a major factor in AE susceptibil-
ity. From a mechanistic point of view, 
developing topical applications that 
improve the stratum corneum should 
therefore result in improvement for 
many patients with AE despite a dis-
tinct genetic contribution to their etiol-
ogy. In addition, the current and future 
impact of high-throughput sequencing 
in understanding genetic disease can-
not be ignored. Since the completion 
of Marenholz and colleagues’ study 
(2011), the 1,000-genome project is 
revealing new sequence variants and 
providing allele frequency data. The 
decreasing costs of high-through-
put sequencing, including exome 
sequencing, allow geneticists to return 
to family-based studies (as opposed 
to the recent focus on identifying 
“low”-risk variants through large-scale 
genome-wide association studies). 
The exome sequencing of AE families 
is likely to reveal “private” genetic 
variation linked to AE susceptibility, 
which may be family specific—akin 
to that revealed for many monogenic 
skin diseases. The question is whether 
the majority will still be found within 
the EDC.
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Clinical Implications
•  Nonfilaggrin epidermal differentiation gene variants are risk factors for 
atopic eczema.
•  A small proline-rich protein gene variant contributes to atopic eczema 
susceptibility.
•  Technical advances and the human genomic knowledge explosion 
suggest imminent identification of additional genetic contributors to 
atopic eczema.
table 1. nonsynonymous sequence variation at the SPrr3 locus
Variation ID Variation type effect on protein
rs67156933 Deletion In-frame 8-amino-acid insertion/deletion
rs28989168 Deletion In-frame 8-amino-acid insertion/deletion
rs66616552 Deletion In-frame 8-amino-acid insertion/deletion
rs17845559 Nonsynonymous coding Amino acid substitution (valine or leucine)
rs1055935 Nonsynonymous coding Amino acid substitution (leucine or valine)
rs2075740 Nonsynonymous coding Amino acid substitution (threonine or methionine)
rs28989168 (in bold) is the insertion polymorphism associated with atopic eczema in the study by Marenholz et al. (2011). The other five coding 
polymorphisms were not genotyped.
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Cutaneous Squamous Cell 
Carcinoma: A Smoking Gun  
but Still No Suspects
John T. Schiller1 and Christopher B. Buck1
A viral etiology for cutaneous squamous cell carcinoma (cuSCC) has long 
been suspected, primarily on the basis of its dramatically increased incidence 
in immunocompromised individuals. In this issue, Arron and colleagues 
report a comprehensive hunt for viral gene transcription in cuSCC. Their find-
ings show that it is very unlikely that any currently known virus is commonly 
responsible for the maintenance of this cancer.
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Identification of a viral cause of a 
human cancer is desirable because 
it provides unique opportunities for 
intervention, particularly prevention. 
This is well illustrated by the recently 
introduced prophylactic vaccine to 
prevent infection by the sexually trans-
mitted human papillomavirus (HPV) 
types most frequently associated 
with cervical and other anogeni-
tal and oral cancers. A common 
“smoking gun” trait of cancers with 
a well-documented viral etiology is 
their increased incidence in immuno-
compromised individuals (Grulich et 
al., 2007). This is presumably attrib-
utable to impaired immunological 
control over what might otherwise be 
a harmless infection. Risk of nonmela-
noma skin cancer, including cutane-
ous squamous cell carcinoma (cuSCC), 
is dramatically increased after immu-
nosuppression, with a more than 
50-fold increase in incidence among 
recipients of solid-organ transplants. It 
has therefore long been suspected that 
cuSCC may be caused by an infectious 
agent. Significant attention has been 
focused on cutaneous HPVs, particu-
larly those from papillomavirus genus-
b (b-HPV), because they ubiquitously 
and chronically infect the skin and are 
clearly implicated in skin carcinogen-
esis in a rare genodermatosis known 
as epidermodysplasia verruciformis 
(Feltkamp et al., 2008).
The conclusion that the association 
of mucosatropic HPVs with anogeni-
tal cancers is causal is supported by 
many lines of laboratory and epide-
miological evidence. The consistent 
maintenance of the viral genome, as 
well as ongoing transcription of the 
viral oncogenes in essentially every 
cell of the tumor, is a central compo-
nent of this causal inference. To date, 
the evidence suggesting a causal role 
for cutaneous HPVs in cuSCC in the 
general population has been mixed, at 
best (Nindl et al., 2007). b-HPV DNA 
is frequently detected in cuSCC, and 
some studies have detected higher 
serological responses to b-HPV virions 
in cases than in controls. However, 
viral DNA is also frequently detected 
in normal skin and, in studies that 
have evaluated viral genome copy 
number in cuSCC tumor specimens, 
this number was usually much less 
than one viral genome per tumor cell. 
Because these studies used HPV DNA 
and serological assays designed to 
evaluate only a few of the many doz-
ens of known HPV species, they left 
open the possibility that an unstudied 
subset of HPV types not targeted by 
the assays was more strongly associ-
ated with cuSCC.
In this issue, Arron and colleagues 
report their use of the powerful new 
technology of high-throughput mRNA 
sequencing to provide an unbiased 
and comprehensive assessment of 
the causal role of HPV gene expres-
sion in cuSCC. Using random prim-
ers, they amplified and sequenced 
a representative fraction of the total 
transcriptosome from 31 cuSCC and 
8 patient-paired normal skin biop-
sies, with an impressive mean count 
of 3.5 million reads per sample. The 
sequence reads, averaging 54 nucleo-
tides in length, were compared with a 
database of all known viruses. Only 
